Ropes & Gray LLP

Ropes & Gray LLP is a global law firm with more than 1,500 attorneys across 16 offices on three continents. The firm maintains a significant healthcare and life sciences practice, providing legal services spanning regulatory compliance, transactions, litigation, and strategic advisory to healthcare organizations, pharmaceutical companies, medical device manufacturers, and digital health companies.

The firm's healthcare capabilities include FDA regulatory strategy, life sciences licensing and collaborations, healthcare transactions and M&A, health privacy and security compliance, managed care, Medicare and Medicaid reimbursement, and digital health regulatory matters. Their approach combines deep regulatory expertise with transactional and litigation experience across the healthcare ecosystem.

Ranked #2 on The American Lawyer's 2025 A-List and named Law Firm of the Year in 2022, Ropes & Gray completed 139,000+ pro bono hours in 2024. The firm has maintained a position in the top three of The American Lawyer's A-List for nine consecutive years, demonstrating sustained excellence across practice areas including their healthcare vertical.

Choose Ropes & Gray when facing complex FDA regulatory challenges, significant healthcare transactions, or high-stakes enforcement matters requiring elite legal counsel. The firm excels in situations demanding deep regulatory expertise combined with transactional sophistication, such as pharmaceutical licensing agreements, healthcare system mergers, or navigating novel digital health regulatory frameworks.

Engagement typically involves dedicated partner-level attention with specialized teams assembled based on specific matter requirements. Clients should expect comprehensive legal analysis, proactive regulatory strategy, and access to cross-practice resources spanning corporate, IP, privacy, and litigation as healthcare matters require.

Ropes & Gray maintains dedicated healthcare and life sciences practices serving the full spectrum of healthcare industry participants. Their FDA regulatory practice provides strategic counsel on pharmaceuticals, biologics, and medical devices from development through post-approval compliance. The firm's healthcare transactional team handles M&A, licensing, and collaborations across pharma, biotech, medical devices, hospitals, and digital health.

Specific healthcare verticals served include managed care organizations, biomedical research institutions, health information technology companies, and healthcare providers navigating Medicare/Medicaid reimbursement and regulatory compliance. The firm addresses healthcare-specific regulatory frameworks including HIPAA, FDA regulations, drug pricing requirements, and anti-kickback statutes.

The ideal client is a large pharmaceutical, biotechnology, or medical device company; major healthcare system or payer; or well-funded digital health company with complex regulatory requirements and significant transactions. These organizations value deep regulatory expertise, have substantial legal budgets, and require counsel capable of handling sophisticated, high-stakes matters with potential regulatory, commercial, and reputational implications.